Literature DB >> 6821614

Factors influencing R wave amplitude in patients with ischaemic heart disease.

J E Deanfield, G Davies, F Mongiadi, C Savage, A P Selwyn, K M Fox.   

Abstract

R wave amplitude changes during exercise have been ascribed to alteration in left ventricular volume and their measurement advocated for the improved diagnosis of coronary disease. The reproducibility of exercise QRS changes and their relation to ST segment depression, respiratory pattern, and left ventricular volume during ischaemia were studied in 10 patients with angina and coronary disease. QRS amplitude was measured in a 16 lead precordial map during three identical exercise tests in each patient and left ventricular volume assessed continuously using gated blood pool imaging with a single scintillation probe during manoeuvres to provoke ischaemia. During exercise, QRS amplitude increased or remained unchanged in four patients and fell in six patients in a consistent manner for each patient. R wave amplitude was not affected by changes in respiratory pattern. R wave amplitude did not alter in 33 of 39 episodes of left ventricular volume increase (mean 32%) or decrease (mean 36%) in end-diastolic counts. These findings suggest that precordial R wave changes during ischaemia are not determined primarily by alteration in left ventricular volume or the respiratory pattern. Though reproducible in each patient and following a definite relation to ST segment depression, the variable directional response during exercise suggest that R wave amplitude changes have little diagnostic value.

Entities:  

Mesh:

Year:  1983        PMID: 6821614      PMCID: PMC485202          DOI: 10.1136/hrt.49.1.8

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  18 in total

1.  Evaluation of R wave amplitude changes versus ST-segment depression in stress testing.

Authors:  P E Bonoris; P S Greenberg; G W Christison; M J Castellanet; M H Ellestad
Journal:  Circulation       Date:  1978-05       Impact factor: 29.690

Review 2.  Monitoring cardiac function with nuclear techniques.

Authors:  G P Leitl; J W Buchanan; H N Wagner
Journal:  Am J Cardiol       Date:  1980-12-18       Impact factor: 2.778

3.  QRS changes in coronary artery disease.

Authors:  M L Simoons
Journal:  Circulation       Date:  1979-04       Impact factor: 29.690

4.  Effects of changes in ventricular size on regional and surface QRS amplitudes in the conscious dog.

Authors:  A Battler; V F Froelicher; K P Gallagher; T Kumada; D McKown; W S Kemper; J Ross
Journal:  Circulation       Date:  1980-07       Impact factor: 29.690

5.  R-wave amplitude variations during acute experimental myocardial ischemia: an inadequate index for changes in intracardiac volume.

Authors:  D David; M Naito; C C Chen; E L Michelson; J Morganroth; M Schaffenburg
Journal:  Circulation       Date:  1981-06       Impact factor: 29.690

6.  R wave amplitude during exercise. Relation to left ventricular function and coronary artery disease.

Authors:  D W Baron; C Ilsley; I Sheiban; P A Poole-Wilson; A F Rickards
Journal:  Br Heart J       Date:  1980-11

7.  Relationship of QRS amplitude changes during exercise to left ventricular function and volumes and the diagnosis of coronary artery disease.

Authors:  A Battler; V Froelicher; R Slutsky; W Ashburn
Journal:  Circulation       Date:  1979-11       Impact factor: 29.690

8.  Unreliability of exercise-induced R wave changes as indexes of coronary artery disease.

Authors:  S Wagner; K Cohn; A Selzer
Journal:  Am J Cardiol       Date:  1979-12       Impact factor: 2.778

9.  Significance of changes in R wave amplitude during treadmill stress testing: angiographic correlation.

Authors:  P E Bonoris; P S Greenberg; M J Castellanet; M H Ellestad
Journal:  Am J Cardiol       Date:  1978-05-01       Impact factor: 2.778

10.  Monitoring ventricular function at rest and during exercise with a nonimaging nuclear detector.

Authors:  H N Wagner; P Rigo; R H Baxter; P O Alderson; K H Douglass; D F Housholder
Journal:  Am J Cardiol       Date:  1979-05       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.